Shinva Medical: Net loss of 12.8697 million yuan in the first half of 2025.

Shineway Biotech announced that its operating income in the first half of 2025 was 122 million yuan, a year-on-year decrease of 3.68%. The net loss attributable to shareholders of the listed company was 12.8697 million yuan, compared to a net loss of 34.508 million yuan in the same period of the previous year.